申请人:CADILA HEALTHCARE LTD
公开号:WO2012073256A1
公开(公告)日:2012-06-07
The present invention relates to pharmaceutically acceptable salts of rosuvastatin of Formula (II), (II) wherein B is an organic amine selected from lysine, arginine, triethanol amine, ethanolamine, choline, epolamine, meglumine and ethylenediamine and process for the preparation thereof.
本发明涉及公认为药用的罗伐他汀的盐,其化学式为(II),其中B为从赖氨酸、精氨酸、三乙醇胺、乙醇胺、胆碱、依普拉明、甲糠醇胺和乙二胺中选择的有机胺,并提供了其制备方法。